Article: PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE-PART II.
Transactions of the American Clinical and Climatological Association
2022 Volume 132, Page(s) 236–248
Abstract: In the United States, primary stroke prevention in children with sickle cell anemia (SCA) is the standard of care and includes annual transcranial Doppler ultrasound to detect elevated velocities. For children with velocities ≥200 cm/sec, initial monthly ...
Abstract | In the United States, primary stroke prevention in children with sickle cell anemia (SCA) is the standard of care and includes annual transcranial Doppler ultrasound to detect elevated velocities. For children with velocities ≥200 cm/sec, initial monthly blood transfusion therapy for at least a year, followed by the option of hydroxyurea therapy, results in a significant decline in the stroke rate. In Africa, no prior strategy exists for primary stroke prevention because regular blood transfusion therapy is not feasible. We completed a randomized controlled trial for primary stroke prevention using initial low- and moderate-dose hydroxyurea as an alternative to blood transfusion therapy. The trial results demonstrated equal primary stroke prevention efficacy with both doses. After the trial, we provided a state-supported stroke screening service and treatment for over 20,000 children in Kano, Nigeria. We will review the strategies implemented to conduct clinical research and provide humanitarian assistance to children with SCA in Nigeria. |
---|---|
MeSH term(s) | Anemia, Sickle Cell/complications ; Anemia, Sickle Cell/therapy ; Antisickling Agents/therapeutic use ; Child ; Humans ; Hydroxyurea/therapeutic use ; Nigeria ; Stroke/diagnostic imaging ; Stroke/etiology ; Stroke/prevention & control |
Chemical Substances | Antisickling Agents ; Hydroxyurea (X6Q56QN5QC) |
Language | English |
Publishing date | 2022-10-04 |
Publishing country | United States |
Document type | Journal Article ; Randomized Controlled Trial |
ZDB-ID | 603823-2 |
ISSN | 0065-7778 |
ISSN | 0065-7778 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 4: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.